The Center for AIDS Information & Advocacy
The CFA advocates both locally and nationally for better treatments and better access to care for persons living with HIV/AIDS and strives to keep the Houston medical and affected community informed, updated, and involved in the search for a cure. The CFA also publishes Research Initiative/Treatment Action! (RI_TA!_). This quarterly journal provides the latest HIV/AIDS information to the medical and HIV communities.
Research Initiative/Treatment Action (RI_TA!) is a publication of The Center for AIDS (CFA). RI_TA! covers issues in HIV research and policy, and is intended for the HIV medical, research, and professional communities. The statements and opinions expressed herein do not imply recommendations or endorsement. Always consult your doctor before altering a prescribed drug regimen or taking any drug or supplement.
RI_TA!_ is available in print or online, and is currently produced four times a year. The printed publication is free of charge for people with HIV/AIDS, the agencies that serve the HIV/AIDS infected and affected population, and research and educational institutions. It is available in print at The CFA information center and by mail.
RI_TA!_ is distributed widely in the U.S. and sent to more than a dozen countries. The publication is indexed by the National Library of Medicine in PubMed and is included in several other free and commercial databases.
Letters to the editor, pertaining to material published in RI_TA!_, are encouraged and may be sent to email@example.com. Letters will be published at the editor's discretion, and may be modified or edited as deemed necessary or appropriate.
If you would like RI_TA!_ sent to you or your organization, please contact The CFA with your full mailing address. Bulk mailings are not available for RI_TA!_ (single copies only) unless the recipient pays for shipping and handling (contact The CFA for details). Although the publication is free, donations are always appreciated to help with publication and shipping costs.
How to Reach the Center for AIDS
P.O. Box 66306
Houston, TX 77266-6306
Houston, TX 77006
Toll Free: 888.341.1788
Latest by The Center for AIDS Information & Advocacy
Quitting smoking can certainly be a tough commitment to make. For HIV-positive smokers who may be struggling to quit, here are 10 things to know.
How can people with HIV prevent and manage diabetes? This guide can help.
Syphilis is a growing threat to gay and bisexual men with and without HIV. Syphilis rates have also climbed recently in women with and without HIV. Syphilis can spread through anal, vaginal, or oral sex. Oral sex is not "safe sex" when it comes t...
Table of Contents
Introduction 25 Things You Need to Do if You Have HIV
If you have HIV, start care as soon as possible with a health care provider or medical group that has HIV experience. With your HIV provider's help, decide when to ...
Emtriva capsules are half light blue and half white. The light-blue half shows the dose (200 mg) and the white half says "Gilead" with the Gilead corporate logo on the left. There is also an oral solution available for Emtriva.
Background and Descri...
Hivid is supplied in 0.750 mg tablets (shown) that are oval, gray, film-coated and imprinted with "HIVID 0.750" on one side and "Roche" on the other side. The drug is also supplied in 0.375 mg tablets that are oval, beige, film-coated and imprinted w...
Kaletra tablets are light yellow-orange with the Abbott corporate logo and "KA" engraved on one side. Each tablet contains 200 mg of lopinavir and 50 mg of Norvir. A yellow-orange liquid formulation (42.4% alcohol) is also available, which contains 4...
Zidovudine is supplied most commonly in film-coated tablets (300 mg, biconvex, round and white) with "GXCW3" on one side and "300" on the other. The drug also comes in capsules (100 mg), flavored syrup, and an intravenous infusion. Dosing may vary.
What should I do if I have been through an emergency situation, such as a hurricane, fire, or earthquake?
Anyone who has been through an emergency situation, been exposed to flood waters or contaminated air or water, been forced to evacuate, etc. sh...
The 150-mg soft, gelatin capsule of Agenerase (shown) was large, cream-white, oblong, and imprinted with "GX CC2" on one side. However, beginning in 2005, the drug is only available in 50-mg capsules and as a flavored solution (mainly for pediatric u...